BJARNASON, G. A. Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?. Canadian Urological Association Journal, [S. l.], v. 10, n. 11-12, p. S252–5, 2016. DOI: 10.5489/cuaj.4293. Disponível em: https://cuaj.ca/index.php/journal/article/view/4293. Acesso em: 26 apr. 2024.